Caribou Biosciences, Inc. (CRBU)
USD 0.88
(9.75%)
USD 0.88
(9.75%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | -93.29 Million | -90.96 Million | -32.51 Million | -33.21 Million | -32 Million |
| Net Income | -102.07 Million | -99.42 Million | -66.92 Million | -34.3 Million | -23.43 Million |
| Depreciation & Amortization | 3.52 Million | 1.62 Million | 984 Thousand | 900 Thousand | 751 Thousand |
| Deferred income taxes | 177 Thousand | -95 Thousand | -1.52 Million | 803 Thousand | - |
| Stock-based compensation | 13.75 Million | 11.71 Million | 3.44 Million | 1 Million | 1.23 Million |
| Change in working capital | -7.31 Million | -4.2 Million | 29.06 Million | 177 Thousand | -8.26 Million |
| Other non-cash items | -1.35 Million | -584 Thousand | 2.42 Million | -1.78 Million | -2.29 Million |
| Investing Cash Flow | -68.18 Million | -93.24 Million | -176.39 Million | 6.36 Million | 27.23 Million |
| Investments in PPE | -11.61 Million | -7.05 Million | -3.12 Million | -1.31 Million | -884 Thousand |
| Acquisitions | -4.42 Million | 600 Thousand | - | 10 Thousand | - |
| Investment purchases | -394.75 Million | -339.06 Million | -173.27 Million | -10 Thousand | - |
| Sales/Maturities of investments | 338.18 Million | 252.86 Million | - | 7.66 Million | 28.11 Million |
| Other Investing Activities | 4.42 Million | -600 Thousand | -1 Million | 10 Thousand | 28.11 Million |
| Financing Cash Flow | 154.29 Million | 2.13 Million | 433.42 Million | 1.73 Million | 172 Thousand |
| Debt repayment | - | - | -119 Thousand | -113 Thousand | -45 Thousand |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | 154.29 Million | 2.13 Million | 321.02 Million | 270 Thousand | 217 Thousand |
| Other Financing Activities | 137 Million | 2.13 Million | 112.52 Million | 1.57 Million | 172 Thousand |
| Accounts receivables | 805 Thousand | 951 Thousand | -1 Million | -146 Thousand | 617 Thousand |
| Accounts payables | 1.81 Million | -2.72 Million | 1.13 Million | 43 Thousand | 1.17 Million |
| Inventory | - | - | -2.2 Million | 1.35 Million | -2.22 Million |
| Other working capital | -9.94 Million | -2.43 Million | 31.13 Million | -1.07 Million | -7.83 Million |
| Cash at beginning of period | 58.33 Million | 240.46 Million | 15.95 Million | 41.07 Million | 45.67 Million |
| Cash at end of period | 51.16 Million | 58.38 Million | 240.46 Million | 15.95 Million | 41.07 Million |
| Capital Expenditure | -11.61 Million | -7.05 Million | -3.12 Million | -1.31 Million | -884 Thousand |
| Effect of forex changes on cash | - | - | - | - | - |
| Net cash flow / Change in cash | -7.17 Million | -182.08 Million | 224.51 Million | -25.11 Million | -4.6 Million |
| Free Cash Flow | -104.9 Million | -98.02 Million | -35.64 Million | -34.53 Million | -32.89 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -37.69 Million | -41.23 Million | -34.5 Million | -102.07 Million | -10 Million | -29.51 Million |
| Depreciation & Amortization | 856 Thousand | 710 Thousand | 1.97 Million | 3.52 Million | 1.57 Million | 617 Thousand |
| Deferred income taxes | - | - | -5.49 Million | 177 Thousand | -2.44 Million | -2.12 Million |
| Stock-based compensation | 4.73 Million | 3.98 Million | 3.55 Million | 13.75 Million | 3.47 Million | 3.58 Million |
| Change in working capital | 2.86 Million | -849 Thousand | 5.02 Million | -7.31 Million | -22.06 Million | 12.08 Million |
| Other non-cash items | 4.49 Million | 2.62 Million | 8.06 Million | -1.35 Million | 666 Thousand | 169 Thousand |
| Investing Cash Flow | 21.2 Million | 22.95 Million | -31.47 Million | -68.18 Million | -68.47 Million | 11.06 Million |
| Investments in PPE | -2.24 Million | -1.44 Million | -2.27 Million | -11.61 Million | -4.75 Million | -2.55 Million |
| Acquisitions | - | - | 29.19 Million | -4.42 Million | 63.72 Million | -13.61 Million |
| Investment purchases | -84.23 Million | -71.18 Million | -84.19 Million | -394.75 Million | -175.89 Million | -58.74 Million |
| Sales/Maturities of investments | 107.8 Million | 97.08 Million | 54.99 Million | 338.18 Million | 112.16 Million | 72.36 Million |
| Other Investing Activities | -125 Thousand | -1.5 Million | -29.19 Million | 4.42 Million | -63.72 Million | 13.61 Million |
| Financing Cash Flow | 132 Thousand | 12.48 Million | -43 Thousand | 154.29 Million | 135.12 Million | 17.57 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | 667 Thousand | -43 Thousand | - | - | - |
| Common Stock Issuance | 132 Thousand | 12.48 Million | -43 Thousand | 154.29 Million | 134.37 Million | 17.33 Million |
| Other Financing Activities | 132 Thousand | 489 Thousand | 135.5 Million | 137 Million | 753 Thousand | 236 Thousand |
| Accounts receivables | 697 Thousand | 245 Thousand | 1.27 Million | 805 Thousand | -367 Thousand | 767 Thousand |
| Accounts payables | -2.36 Million | 2.72 Million | 730 Thousand | 1.81 Million | -953 Thousand | 540 Thousand |
| Inventory | - | - | -5.27 Million | - | 819 Thousand | 4.45 Million |
| Other working capital | 4.53 Million | -3.81 Million | 3.01 Million | -9.94 Million | -21.56 Million | 6.32 Million |
| Cash at beginning of period | 49.4 Million | 51.16 Million | 104.05 Million | 58.33 Million | 66.24 Million | 52.79 Million |
| Cash at end of period | 37.86 Million | 49.4 Million | 51.16 Million | 51.16 Million | 104.1 Million | 66.24 Million |
| Capital Expenditure | -2.24 Million | -1.44 Million | -2.27 Million | -11.61 Million | -4.75 Million | -2.55 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -11.53 Million | -1.76 Million | -52.89 Million | -7.17 Million | 37.86 Million | 13.45 Million |
| Free Cash Flow | -35.1 Million | -38.65 Million | -23.65 Million | -104.9 Million | -33.54 Million | -17.73 Million |
300146
002050
CDG
1626
600052
3658